Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies.

about

Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies.

Item

http://www.wikidata.org/entity/Q44600407

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Maximizing output from current ...... xt-generation immunotherapies.

@en

Maximizing output from current ...... xt-generation immunotherapies.

@nl

type

Item

label

Maximizing output from current ...... xt-generation immunotherapies.

@en

Maximizing output from current ...... xt-generation immunotherapies.

@nl

prefLabel

Maximizing output from current ...... xt-generation immunotherapies.

@en

Maximizing output from current ...... xt-generation immunotherapies.

@nl

P1476

Maximizing output from current ...... ext-generation immunotherapies

@en

P2093

Pierre-Yves Dietrich

http://www.w3.org/2001/XMLSchema#string

P2860

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

Adoptive immunotherapy for cancer: harnessing the T cell response

Cancer immunotherapy comes of age

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients.

Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.

P304

1147-1150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/IMT.13.115

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Denis Migliorini

P R Walker

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24188666

http://www.w3.org/2001/XMLSchema#string